Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Matsunaga

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Cancer Chemotherapy and Pharmacology|July 20, 2005
Phase I and pharmacokinetic study of amrubicin, a synthetic 9-aminoanthracycline, in patients with refractory or relapsed lung cancerIsamu Okamoto, Akinobu Hamada, Yusuke Matsunaga, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 10, 2025
Risk of liver dysfunction with ACE inhibitors based on real-world data from the MID-NET<sup>®</sup> in JapanYuki Kinoshita, Takashi Ando, Kazuhiro Kajiyama, et al.
Journal of Bone and Mineral Metabolism|January 17, 2018
Association between frailty and bone loss in patients undergoing maintenance hemodialysisKei Yoneki, Jun Kitagawa, Keika Hoshi, et al.
BMJ Open|May 25, 2019
Effects of electrical muscle stimulation in frail elderly patients during haemodialysis (DIAL): rationale and protocol for a crossover randomised controlled trialYuta Suzuki, Kentaro Kamiya, Shinya Tanaka, et al.
Kidney & Blood Pressure Research|October 5, 2018
Utility of Regular Management of Physical Activity and Physical Function in Hemodialysis PatientsShohei Yamamoto, Ryota Matsuzawa, Yoshifumi Abe, et al.
International Urology and Nephrology|August 16, 2020
Perceived difficulty in activities of daily living and survival in patients receiving maintenance hemodialysisTakaaki Watanabe, Toshiki Kutsuna, Yuta Suzuki, et al.
Stem Cells (Dayton, Ohio)|August 11, 2007
Genetically manipulated human embryonic stem cell-derived dendritic cells with immune regulatory functionSatoru Senju, Hirofumi Suemori, Hitoshi Zembutsu, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Cancer Chemotherapy and Pharmacology|July 20, 2005
Phase I and pharmacokinetic study of amrubicin, a synthetic 9-aminoanthracycline, in patients with refractory or relapsed lung cancerIsamu Okamoto, Akinobu Hamada, Yusuke Matsunaga, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 10, 2025
Risk of liver dysfunction with ACE inhibitors based on real-world data from the MID-NET<sup>®</sup> in JapanYuki Kinoshita, Takashi Ando, Kazuhiro Kajiyama, et al.
Journal of Bone and Mineral Metabolism|January 17, 2018
Association between frailty and bone loss in patients undergoing maintenance hemodialysisKei Yoneki, Jun Kitagawa, Keika Hoshi, et al.
BMJ Open|May 25, 2019
Effects of electrical muscle stimulation in frail elderly patients during haemodialysis (DIAL): rationale and protocol for a crossover randomised controlled trialYuta Suzuki, Kentaro Kamiya, Shinya Tanaka, et al.
Kidney & Blood Pressure Research|October 5, 2018
Utility of Regular Management of Physical Activity and Physical Function in Hemodialysis PatientsShohei Yamamoto, Ryota Matsuzawa, Yoshifumi Abe, et al.
International Urology and Nephrology|August 16, 2020
Perceived difficulty in activities of daily living and survival in patients receiving maintenance hemodialysisTakaaki Watanabe, Toshiki Kutsuna, Yuta Suzuki, et al.
Stem Cells (Dayton, Ohio)|August 11, 2007
Genetically manipulated human embryonic stem cell-derived dendritic cells with immune regulatory functionSatoru Senju, Hirofumi Suemori, Hitoshi Zembutsu, et al.
Pageof 3